(MOVE) Movano - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US62459M1071
MOVE EPS (Earnings per Share)
MOVE Revenue
MOVE: Wearable Devices, Health Sensors, Monitoring
Movano Inc. is a technology-driven healthcare company that has developed a cutting-edge platform to deliver innovative healthcare solutions at the intersection of medical and consumer devices. The companys flagship product, Evie Ring, is a wearable device designed specifically for women, offering a comprehensive suite of health and wellness metrics, including resting heart rate, heart rate variability, blood oxygen saturation, and more. By tracking these metrics, Evie Ring provides users with valuable insights into their overall health and wellbeing.
In addition to Evie Ring, Movano is also developing System-on-a-Chip (SoC) technology for blood pressure and continuous glucose monitoring (CGM) systems, positioning the company for potential growth in the rapidly expanding wearables and healthcare technology markets. With a diverse sales strategy that includes direct-to-consumer sales through its website, retail partnerships, and OEM collaborations, Movano is well-positioned to reach a broad customer base.
From a technical analysis perspective, Movanos stock has experienced significant volatility, with a 52-week high of $6.77 and a low of $0.56, the current price. The stock is currently trading below its 20-day, 50-day, and 200-day simple moving averages, indicating a downtrend. The Average True Range (ATR) of 0.15 represents a 27.18% volatility, suggesting that the stock is highly volatile. Based on this technical data, it is likely that the stock will continue to experience significant price swings in the short term.
Fundamentally, Movanos market capitalization is approximately $6.32M USD, with no reported earnings per share (EPS) or forward EPS. The companys return on equity (ROE) is -216.80, indicating significant losses. Given the companys current financial situation and the competitive landscape of the wearables and healthcare technology markets, it is challenging to predict when the company will achieve profitability. However, if Movano can successfully execute on its product roadmap and expand its customer base, there is potential for long-term growth.
Forecasting Movanos stock performance is challenging due to the high volatility and lack of profitability. However, based on the technical and fundamental data, a possible scenario is that the stock may continue to experience a downtrend in the short term, potentially testing the 52-week low of $0.56. If the company can demonstrate progress on its product development and sales strategy, a potential rebound could occur. A key catalyst to watch will be the companys ability to expand its customer base and achieve scale, which could potentially drive growth and improve investor sentiment. Assuming a successful execution of its business plan, a potential price target could be in the range of $2-$5 per share over the next 12-18 months, representing a significant increase from current levels. However, this is a highly speculative forecast and should be taken with caution.
Additional Sources for MOVE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
MOVE Stock Overview
Market Cap in USD | 5m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Technology Hardware, Storage & Peripherals |
IPO / Inception | 1999-08-05 |
MOVE Stock Ratings
Growth Rating | -81.7 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -89 |
Analysts | 4 of 5 |
Fair Price Momentum | 0.31 USD |
Fair Price DCF | - |
MOVE Dividends
Currently no dividends paidMOVE Growth Ratios
Growth Correlation 3m | -84% |
Growth Correlation 12m | -65.1% |
Growth Correlation 5y | -98.4% |
CAGR 5y | -69.37% |
CAGR/Max DD 5y | -0.70 |
Sharpe Ratio 12m | -0.83 |
Alpha | -108.23 |
Beta | 2.009 |
Volatility | 112.26% |
Current Volume | 107.2k |
Average Volume 20d | 342.3k |
As of June 16, 2025, the stock is trading at USD 0.66 with a total of 107,183 shares traded.
Over the past week, the price has changed by -11.88%, over one month by -36.54%, over three months by -74.12% and over the past year by -89.56%.
No, based on ValueRay´s Analyses, Movano (NASDAQ:MOVE) is currently (June 2025) a stock to sell. It has a ValueRay Growth Rating of -81.71 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MOVE is around 0.31 USD . This means that MOVE is currently overvalued and has a potential downside of -53.03%.
Movano has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy MOVE.
- Strong Buy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, MOVE Movano will be worth about 0.4 in June 2026. The stock is currently trading at 0.66. This means that the stock has a potential downside of -43.94%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 30 | 4445.5% |
Analysts Target Price | 30 | 4445.5% |
ValueRay Target Price | 0.4 | -43.9% |